Status:
COMPLETED
C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)
Lead Sponsor:
AstraZeneca
Conditions:
Cardiovascular Risk
Eligibility:
All Genders
18+ years
Brief Summary
To demonstrate a higher percent rate of achieved target lipid goals among patients at high cardiovascular risk using more potent lipid-lowering treatment options including high-potency statins and com...
Eligibility Criteria
Inclusion
- Patients at high cardiovascular risk according to Framingham or SCORE rates
Exclusion
- Not eligible for lipid or statin therapy
- Intolerance to therapy
- Patients at low or intermediate CV risk
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00921752
Start Date
May 1 2009
End Date
November 1 2009
Last Update
December 4 2009
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Baja, Hungary
2
Research Site
Békéscsaba, Hungary
3
Research Site
Budapest, Hungary
4
Research Site
Budapest III District, Hungary